{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:21:55Z","timestamp":1788153715176,"version":"build-2803163510"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01969-8","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:25:25Z","timestamp":1788150325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Harnessing the neuroprotective potential of estrogen in Parkinson\u2019s disease: an insight into molecular mechanisms and therapeutic approaches"],"prefix":"10.1007","volume":"41","author":[{"given":"Ashmit","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2018-8402","authenticated-orcid":false,"given":"Shubham","family":"Upadhayay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"1969_CR1","doi-asserted-by":"publisher","first-page":"577426","DOI":"10.1016\/j.jneuroim.2020.577426","volume":"349","author":"Y Aguirre-Vidal","year":"2020","unstructured":"Aguirre-Vidal Y, Morales-Montor J, de Le\u00f3n CTG, Ostoa-Saloma P, D\u00edaz-Zaragoza M, Montes S, Monroy-Noyola A (2020) Protection induced by estradiol benzoate in the MPP\u2009+\u2009rat model of Parkinson\u2019s disease is associated with the regulation of the inflammatory cytokine profile in the nigro striatum. J Neuroimmunol 349:577426","journal-title":"J Neuroimmunol"},{"key":"1969_CR2","doi-asserted-by":"publisher","unstructured":"Ahmed HA, Makled MN, Ibrahim TM, Shaaban AA (2024) Protective role of female estrogens and estrogen receptors especially GPER receptor activation on body systems and diseases: a review. Delta Univ Sci J 7(2):24\u201338. https:\/\/doi.org\/10.21608\/dusj.2024.313522.1086","DOI":"10.21608\/dusj.2024.313522.1086"},{"issue":"6","key":"1969_CR3","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/ptr.7870","volume":"37","author":"AS Al-Shami","year":"2023","unstructured":"Al-Shami AS, Essawy AE, Elkader HTAEA (2023) Molecular mechanisms underlying the potential neuroprotective effects of Trifolium pratense and its phytoestrogen\u2010isoflavones in neurodegenerative disorders. Phytother Res 37(6):2693\u20132737","journal-title":"Phytother Res"},{"key":"1969_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yhbeh.2015.06.010","volume":"74","author":"A Almey","year":"2015","unstructured":"Almey A, Milner TA, Brake WG (2015) Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females. Horm Behav 74:125\u2013138","journal-title":"Horm Behav"},{"issue":"11","key":"1969_CR5","doi-asserted-by":"publisher","first-page":"15108","DOI":"10.1007\/s12035-025-05113-y","volume":"62","author":"R AlRuwaili","year":"2025","unstructured":"AlRuwaili R, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Batiha GE-S (2025) Targeting of the PI3 K\/AKT\/GSK3\u03b2 Pathway in Parkinson\u2019s Disease: A Therapeutic Blueprint. Mol Neurobiol 62(11):15108\u201315131","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1969_CR6","doi-asserted-by":"publisher","first-page":"101561","DOI":"10.1016\/j.beem.2021.101561","volume":"35","author":"E Armeni","year":"2021","unstructured":"Armeni E, Paschou SA, Goulis DG, Lambrinoudaki I (2021) Hormone therapy regimens for managing the menopause and premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab 35(6):101561","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1969_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuroscience.2021.03.025","volume":"463","author":"R Aryanpour","year":"2021","unstructured":"Aryanpour R, Zibara K, Pasbakhsh P, Jame\u2019ei SB, Namjoo Z, Ghanbari A, Kashani IR (2021) 17\u03b2-Estradiol reduces demyelination in cuprizone-fed mice by promoting M2 microglia polarity and regulating NLRP3 inflammasome. Neuroscience 463:116\u2013127","journal-title":"Neuroscience"},{"issue":"9","key":"1969_CR8","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/ijms22094676","volume":"22","author":"K Badanjak","year":"2021","unstructured":"Badanjak K, Fixemer S, Smaji\u0107 S, Skupin A, Gr\u00fcnewald A (2021) The contribution of microglia to neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 22(9):4676","journal-title":"Int J Mol Sci"},{"key":"1969_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2017.02.021","volume":"1662","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T, Rabiee N, Zabihnejad S, Roghani M (2017) Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson\u2019s disease: Possible involvement of ER\u03b2\/Nrf2\/HO-1 signaling. Brain Res 1662:23\u201330. https:\/\/doi.org\/10.1016\/j.brainres.2017.02.021","journal-title":"Brain Res"},{"issue":"19\u201320","key":"1969_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.lfs.2011.03.010","volume":"88","author":"AM Baraka","year":"2011","unstructured":"Baraka AM, Korish AA, Soliman GA, Kamal H (2011) The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson\u2019s disease. Life Sci 88(19\u201320):879\u2013885","journal-title":"Life Sci"},{"issue":"15","key":"1969_CR11","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.3390\/ijms25158167","volume":"25","author":"J Bartkowiak-Wieczorek","year":"2024","unstructured":"Bartkowiak-Wieczorek J, Jaros A, Gajdzi\u0144ska A, Wojty\u0142a-Buciora P, Szyma\u0144ski I, Szymaniak J, Bienert A (2024) The dual faces of oestrogen: The impact of exogenous oestrogen on the physiological and pathophysiological functions of tissues and organs. Int J Mol Sci 25(15):8167","journal-title":"Int J Mol Sci"},{"key":"1969_CR12","doi-asserted-by":"publisher","first-page":"1348551","DOI":"10.3389\/fnins.2024.1348551","volume":"18","author":"PC Bendis","year":"2024","unstructured":"Bendis PC, Zimmerman S, Onisiforou A, Zanos P, Georgiou P (2024) The impact of estradiol on serotonin, glutamate, and dopamine systems. Front NeuroSci 18:1348551","journal-title":"Front NeuroSci"},{"key":"1969_CR13","doi-asserted-by":"publisher","first-page":"113593","DOI":"10.1016\/j.bbr.2021.113593","volume":"417","author":"A Bernal","year":"2022","unstructured":"Bernal A, Paolieri D (2022) The influence of estradiol and progesterone on neurocognition during three phases of the menstrual cycle: Modulating factors. Behav Brain Res 417:113593","journal-title":"Behav Brain Res"},{"issue":"3","key":"1969_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neurobiolaging.2012.05.022","volume":"34","author":"M Bourque","year":"2013","unstructured":"Bourque M, Morissette M, C\u00f4t\u00e9 M, Soulet D, Di Paolo T (2013) Implication of GPER1 in neuroprotection in a mouse model of Parkinson\u2019s disease. Neurobiol Aging 34(3):887\u2013901","journal-title":"Neurobiol Aging"},{"key":"1969_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.neuropharm.2015.04.006","volume":"95","author":"M Bourque","year":"2015","unstructured":"Bourque M, Morissette M, Di Paolo T (2015) Neuroprotection in Parkinsonian-treated mice via estrogen receptor \u03b1 activation requires G protein-coupled estrogen receptor 1. Neuropharmacology 95:343\u2013352","journal-title":"Neuropharmacology"},{"key":"1969_CR16","doi-asserted-by":"publisher","first-page":"636176","DOI":"10.3389\/fncel.2021.636176","volume":"15","author":"FA Bustamante-Barrientos","year":"2021","unstructured":"Bustamante-Barrientos FA, M\u00e9ndez-Ruette M, Ortloff A, Luz-Crawford P, Rivera FJ, Figueroa CD, B\u00e1tiz LF (2021) The impact of estrogen and estrogen-like molecules in neurogenesis and neurodegeneration: beneficial or harmful? Front Cell Neurosci 15:636176","journal-title":"Front Cell Neurosci"},{"key":"1969_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.freeradbiomed.2021.06.025","volume":"172","author":"J Cao","year":"2021","unstructured":"Cao J, Lu M, Yan W, Li L, Ma H (2021) Dehydroepiandrosterone alleviates intestinal inflammatory damage via GPR30-mediated Nrf2 activation and NLRP3 inflammasome inhibition in colitis mice. Free Radic Biol Med 172:386\u2013402","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1969_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1006\/geno.1997.4972","volume":"45","author":"C Carmeci","year":"1997","unstructured":"Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ (1997) Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45(3):607\u2013617","journal-title":"Genomics"},{"issue":"8","key":"1969_CR19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1210\/me.2005-0334","volume":"20","author":"JS Carroll","year":"2006","unstructured":"Carroll JS, Brown M (2006) Estrogen receptor target gene: an evolving concept. Mol Endocrinol 20(8):1707\u20131714","journal-title":"Mol Endocrinol"},{"issue":"1","key":"1969_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40120-024-00687-6","volume":"14","author":"C Cattaneo","year":"2025","unstructured":"Cattaneo C, Pagonabarraga J (2025) Sex differences in Parkinson\u2019s disease: a narrative review. Neurol therapy 14(1):57\u201370","journal-title":"Neurol therapy"},{"issue":"3","key":"1969_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F (2019) Parkinson\u2019s disease in women and men: what\u2019s the difference? J Parkinson\u2019s disease 9(3):501\u2013515","journal-title":"J Parkinson\u2019s disease"},{"key":"1969_CR22","doi-asserted-by":"publisher","first-page":"839005","DOI":"10.3389\/fendo.2022.839005","volume":"13","author":"P Chen","year":"2022","unstructured":"Chen P, Li B, Ou-Yang L (2022) Role of estrogen receptors in health and disease. Front Endocrinol 13:839005","journal-title":"Front Endocrinol"},{"issue":"2","key":"1969_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12031-016-0856-y","volume":"61","author":"Y-F Cheng","year":"2017","unstructured":"Cheng Y-F, Zhu G, Wu Q-W, Xie Y-S, Jiang Y, Guo L, Zhang J (2017) GPR30 activation contributes to the puerarin-mediated neuroprotection in MPP+-induced SH-SY5Y cell death. J Mol Neurosci 61(2):227\u2013234","journal-title":"J Mol Neurosci"},{"issue":"7","key":"1969_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/mds.23604","volume":"26","author":"SJ Chung","year":"2011","unstructured":"Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Maraganore DM (2011) Variants in estrogen-related genes and risk of Parkinson\u2019s disease. Mov Disord 26(7):1234\u20131242. https:\/\/doi.org\/10.1002\/mds.23604","journal-title":"Mov Disord"},{"issue":"1","key":"1969_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/frne.1999.0188","volume":"21","author":"NA Compagnone","year":"2000","unstructured":"Compagnone NA, Mellon SH (2000) Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocr 21(1):1\u201356","journal-title":"Front Neuroendocr"},{"key":"1969_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nbd.2015.05.017","volume":"82","author":"M C\u00f4t\u00e9","year":"2015","unstructured":"C\u00f4t\u00e9 M, Bourque M, Poirier A-A, Aub\u00e9 B, Morissette M, Di Paolo T, Soulet D (2015) GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson\u2019s disease. Neurobiol Dis 82:99\u2013113. https:\/\/doi.org\/10.1016\/j.nbd.2015.05.017","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1969_CR27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.neuropharm.2004.08.020","volume":"47","author":"M D\u2019Astous","year":"2004","unstructured":"D\u2019Astous M, Morissette M, Di Paolo T (2004) Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER\u03b1 agonist. Neuropharmacology 47(8):1180\u20131188","journal-title":"Neuropharmacology"},{"key":"1969_CR28","doi-asserted-by":"crossref","unstructured":"Das S, Majumdar nee, Paul S (2025) GPER a Potent Target of Xenoestrogens: An Overview on Biological Activity and Mechanism of Action in Cancer and Immunogenic Pathway. Paper presented at the Proceedings of the Zoological Society","DOI":"10.1007\/s12595-025-00570-8"},{"issue":"6","key":"1969_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nchembio.168","volume":"5","author":"MK Dennis","year":"2009","unstructured":"Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Deliu E (2009) In vivo effects of a GPR30 antagonist. Nat Chem Biol 5(6):421\u2013427","journal-title":"Nat Chem Biol"},{"issue":"3","key":"1969_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI27987","volume":"116","author":"BJ Deroo","year":"2006","unstructured":"Deroo BJ, Korach KS (2006) Estrogen receptors and human disease. J Clin Investig 116(3):561\u2013570","journal-title":"J Clin Investig"},{"key":"1969_CR31","doi-asserted-by":"publisher","first-page":"1648904","DOI":"10.3389\/fnmol.2025.1648904","volume":"18","author":"A Digman","year":"2025","unstructured":"Digman A, Pajarillo E, Kim S, Ajayi I, Son DS, Aschner M, Lee E (2025a) Tamoxifen attenuates manganese-induced dysregulation of neuronal REST via the genomic ER-\u03b1 mechanism. Front Mol Neurosci 18:1648904. https:\/\/doi.org\/10.3389\/fnmol.2025.1648904","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"1969_CR32","doi-asserted-by":"publisher","first-page":"108529","DOI":"10.1016\/j.jbc.2025.108529","volume":"301","author":"A Digman","year":"2025","unstructured":"Digman A, Pajarillo E, Kim S, Ajayi I, Son DS, Aschner M, Lee E (2025b) Tamoxifen induces protection against manganese toxicity by REST upregulation via the ER-\u03b1\/Wnt\/\u03b2-catenin pathway in neuronal cells. J Biol Chem 301(6):108529. https:\/\/doi.org\/10.1016\/j.jbc.2025.108529","journal-title":"J Biol Chem"},{"issue":"2","key":"1969_CR33","first-page":"447","volume":"69","author":"N Dong","year":"2022","unstructured":"Dong N, Yang Z (2022) Glycitein exerts neuroprotective effects in Rotenone-triggered oxidative stress and apoptotic cell death in the cellular model of Parkinson\u2019s disease. Acta Biochim Pol 69(2):447\u2013452","journal-title":"Acta Biochim Pol"},{"key":"1969_CR34","doi-asserted-by":"publisher","first-page":"105989","DOI":"10.1016\/j.jsbmb.2021.105989","volume":"214","author":"Z-R Du","year":"2021","unstructured":"Du Z-R, Gu Y, Xie X-M, Zhang M, Jiang G-Y, Chen W-F (2021) GPER and IGF-1R mediate the anti-inflammatory effect of genistein against lipopolysaccharide (LPS)-induced nigrostriatal injury in rats. J Steroid Biochem Mol Biol 214:105989","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1969_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13293-020-0283-1","volume":"11","author":"P Duong","year":"2020","unstructured":"Duong P, Tenkorang MA, Trieu J, McCuiston C, Rybalchenko N, Cunningham RL (2020) Neuroprotective and neurotoxic outcomes of androgens and estrogens in an oxidative stress environment. Biology sex differences 11(1):12","journal-title":"Biology sex differences"},{"issue":"10","key":"1969_CR36","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","volume":"14","author":"EJ Filardo","year":"2000","unstructured":"Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14(10):1649\u20131660","journal-title":"Mol Endocrinol"},{"issue":"7","key":"1969_CR37","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1210\/en.2002-0143","volume":"144","author":"J Frasor","year":"2003","unstructured":"Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS (2003) Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) \u03b1 activity by ER\u03b2 in the uterus. Endocrinology 144(7):3159\u20133166","journal-title":"Endocrinology"},{"issue":"3\u20135","key":"1969_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0960-0760(03)00364-9","volume":"86","author":"J Geisler","year":"2003","unstructured":"Geisler J (2003) Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. J Steroid Biochem Mol Biol 86(3\u20135):245\u2013253","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"1969_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1124\/pr.109.002071","volume":"62","author":"GE Gillies","year":"2010","unstructured":"Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 62(2):155\u2013198","journal-title":"Pharmacol Rev"},{"issue":"3","key":"1969_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","volume":"35","author":"GE Gillies","year":"2014","unstructured":"Gillies GE, Pienaar IS, Vohra S, Qamhawi Z (2014) Sex differences in Parkinson\u2019s disease. Front Neuroendocr 35(3):370\u2013384","journal-title":"Front Neuroendocr"},{"issue":"16","key":"1969_CR41","doi-asserted-by":"publisher","first-page":"8920","DOI":"10.3390\/ijms22168920","volume":"22","author":"C Giuliano","year":"2021","unstructured":"Giuliano C, Francavilla M, Ongari G, Petese A, Ghezzi C, Rossini N, Cerri S (2021) Neuroprotective and symptomatic effects of cannabidiol in an animal model of Parkinson\u2019s disease. Int J Mol Sci 22(16):8920","journal-title":"Int J Mol Sci"},{"key":"1969_CR42","doi-asserted-by":"publisher","first-page":"105480","DOI":"10.1016\/j.parkreldis.2023.105480","volume":"112","author":"P Grillo","year":"2023","unstructured":"Grillo P, Sancesario GM, Bovenzi R, Zenuni H, Bissacco J, Mascioli D, Pieri M (2023) Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients. Parkinsonism Relat Disord 112:105480","journal-title":"Parkinsonism Relat Disord"},{"key":"1969_CR43","doi-asserted-by":"publisher","first-page":"155435","DOI":"10.1016\/j.phymed.2024.155435","volume":"126","author":"Y Gu","year":"2024","unstructured":"Gu Y, Hu Z-F, Zheng D-W, Yang Y-Q, Dong X-L, Chen W-F (2024) Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson\u2019s disease. Phytomedicine 126:155435","journal-title":"Phytomedicine"},{"issue":"1","key":"1969_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000478908","volume":"24","author":"J Guan","year":"2017","unstructured":"Guan J, Yang B, Fan Y, Zhang J (2017) GPER agonist G1 attenuates neuroinflammation and dopaminergic neurodegeneration in Parkinson disease. Neuroimmunomodulation 24(1):60\u201366","journal-title":"Neuroimmunomodulation"},{"key":"1969_CR45","doi-asserted-by":"publisher","first-page":"154124","DOI":"10.1016\/j.phymed.2022.154124","volume":"101","author":"R Han","year":"2022","unstructured":"Han R, Yu Y, Zhao K, Wei J, Hui Y, Gao J-M (2022) Lignans from Eucommia ulmoides Oliver leaves exhibit neuroprotective effects via activation of the PI3K\/Akt\/GSK-3\u03b2\/Nrf2 signaling pathways in H2O2-treated PC-12 cells. Phytomedicine 101:154124","journal-title":"Phytomedicine"},{"issue":"16","key":"1969_CR46","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1111\/bph.16382","volume":"181","author":"B Haridevamuthu","year":"2024","unstructured":"Haridevamuthu B, Sudhakaran G, Pachaiappan R, Kathiravan MK, Manikandan K, Almutairi MH, Arockiaraj J (2024) Daidzein ameliorates nonmotor symptoms of manganese-induced Parkinsonism in zebrafish model: Behavioural and biochemical approach. Br J Pharmacol 181(16):2947\u20132963","journal-title":"Br J Pharmacol"},{"issue":"44","key":"1969_CR47","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1038\/sj.onc.1208807","volume":"24","author":"LA Helguero","year":"2005","unstructured":"Helguero LA, Faulds MH, Gustafsson J-\u00c5, Haldosen L-A (2005) Estrogen receptors alfa (ER\u03b1) and beta (ER\u03b2) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24(44):6605\u20136616","journal-title":"Oncogene"},{"key":"1969_CR48","doi-asserted-by":"publisher","unstructured":"Hevener AL, Correa SM (2025) Metabolic messengers: oestradiol. Nat Metab 7(1):1114\u20131122. https:\/\/doi.org\/10.1038\/s42255-025-01317-7","DOI":"10.1038\/s42255-025-01317-7"},{"key":"1969_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.yhbeh.2016.01.011","volume":"80","author":"CJ Hwang","year":"2016","unstructured":"Hwang CJ, Choi DY, Jung YY, Lee YJ, Yun JS, Oh KW, Hong JT (2016) Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice. Horm Behav 80:19\u201329. https:\/\/doi.org\/10.1016\/j.yhbeh.2016.01.011","journal-title":"Horm Behav"},{"key":"1969_CR50","doi-asserted-by":"crossref","unstructured":"Jalabert C, Ma C, Soma KK (2021) Profiling of systemic and brain steroids in male songbirds: Seasonal changes in neurosteroids. J Neuroendocrinol, 33(1), e12922","DOI":"10.1111\/jne.12922"},{"issue":"2","key":"1969_CR51","doi-asserted-by":"publisher","first-page":"G203","DOI":"10.1152\/ajpgi.00144.2019","volume":"317","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Greenwood-Van Meerveld B, Johnson AC, Travagli RA (2019) Role of estrogen and stress on the brain-gut axis. Am J Physiology-Gastrointestinal Liver Physiol 317(2):G203\u2013G209","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"issue":"5","key":"1969_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/jnci\/djk062","volume":"99","author":"VC Jordan","year":"2007","unstructured":"Jordan VC (2007) SERMs: meeting the promise of multifunctional medicines. J Natl Cancer Inst 99(5):350\u2013356","journal-title":"J Natl Cancer Inst"},{"key":"1969_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yfrne.2017.09.002","volume":"50","author":"JC Jurado-Coronel","year":"2018","unstructured":"Jurado-Coronel JC, Cabezas R, Rodr\u00edguez MF\u00c1, Echeverria V, Garc\u00eda-Segura LM, Barreto GE (2018) Sex differences in Parkinson\u2019s disease: features on clinical symptoms, treatment outcome, sexual hormones and genetics. Front Neuroendocr 50:18\u201330","journal-title":"Front Neuroendocr"},{"issue":"5","key":"1969_CR54","doi-asserted-by":"publisher","first-page":"e02139","DOI":"10.1002\/brb3.2139","volume":"11","author":"M Khaleghi","year":"2021","unstructured":"Khaleghi M, Rajizadeh MA, Bashiri H, Kohlmeier KA, Mohammadi F, Khaksari M, Shabani M (2021) Estrogen attenuates physical and psychological stress-induced cognitive impairments in ovariectomized rats. Brain Behav 11(5):e02139","journal-title":"Brain Behav"},{"issue":"6","key":"1969_CR55","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/antiox10060892","volume":"10","author":"I Khan","year":"2021","unstructured":"Khan I, Saeed K, Jo MG, Kim MO (2021) 17-\u03b2 estradiol rescued immature rat brain against glutamate-induced oxidative stress and neurodegeneration via regulating Nrf2\/HO-1 and MAP-kinase signaling pathway. Antioxidants 10(6):892","journal-title":"Antioxidants"},{"key":"1969_CR56","doi-asserted-by":"publisher","unstructured":"Kim H, Park J, Leem H, Cho M, Yoon JH, Maeng HJ, Lee Y (2019) Rhododendrin-Induced RNF146 Expression via Estrogen Receptor \u03b2 Activation is Cytoprotective Against 6-OHDA-Induced Oxidative Stress. Int J Mol Sci 20(7). https:\/\/doi.org\/10.3390\/ijms20071772","DOI":"10.3390\/ijms20071772"},{"issue":"12","key":"1969_CR57","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","volume":"93","author":"G Kuiper","year":"1996","unstructured":"Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci 93(12):5925\u20135930","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"1969_CR58","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/hipo.22475","volume":"25","author":"A Kumar","year":"2015","unstructured":"Kumar A, Bean LA, Rani A, Jackson T, Foster TC (2015) Contribution of estrogen receptor subtypes, ER \u03b1, ER \u03b2, and GPER1 in rapid estradiol-mediated enhancement of hippocampal synaptic transmission in mice. Hippocampus 25(12):1556\u20131566","journal-title":"Hippocampus"},{"key":"1969_CR59","doi-asserted-by":"publisher","first-page":"113268","DOI":"10.1016\/j.fct.2022.113268","volume":"167","author":"H Li","year":"2022","unstructured":"Li H, Li J, Shi L, Zhu Y, Tian F, Shi M, Ge R-s (2022) Bisphenol F blocks Leydig cell maturation and steroidogenesis in pubertal male rats through suppressing androgen receptor signaling and activating G-protein coupled estrogen receptor 1 (GPER1) signaling. Food Chem Toxicol 167:113268","journal-title":"Food Chem Toxicol"},{"key":"1969_CR60","doi-asserted-by":"publisher","first-page":"1185375","DOI":"10.3389\/fneur.2023.1185375","volume":"14","author":"Q Li","year":"2023","unstructured":"Li Q, Meng L-b, Chen L-j, Shi X, Tu L, Zhou Q, Yuan Q-y (2023) The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson\u2019s disease. Front Neurol 14:1185375","journal-title":"Front Neurol"},{"issue":"5","key":"1969_CR61","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5607\/en25022","volume":"34","author":"Y Liang","year":"2025","unstructured":"Liang Y, Zhou L, Liu H, Huang X, Li Y, Li X, Huang S (2025) G protein-coupled Estrogen Receptor Activation Exerts Protective Effects via Modulating Brain and Gut NLRP3 Inflammasome in Parkinson\u2019s Disease. Experimental Neurobiol 34(5):200","journal-title":"Experimental Neurobiol"},{"key":"1969_CR62","doi-asserted-by":"publisher","first-page":"757714","DOI":"10.3389\/fnagi.2021.757714","volume":"13","author":"AC Lima","year":"2021","unstructured":"Lima AC, Meurer YS, Bioni VS, Cunha DM, Gon\u00e7alves N, Lopes-Silva LB, Santos JR (2021) Female rats are resistant to cognitive, motor and dopaminergic deficits in the reserpine-induced progressive model of parkinson\u2019s disease. Front Aging Neurosci 13:757714","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"1969_CR63","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/FJC.0b013e3182135f1c","volume":"57","author":"SH Lindsey","year":"2011","unstructured":"Lindsey SH, Carver KA, Prossnitz ER, Chappell MC (2011) Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2. Lewis female rat. J Cardiovasc Pharmacol 57(5):598\u2013603","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"1969_CR64","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1471-4159.2004.02518.x","volume":"90","author":"B Liu","year":"2004","unstructured":"Liu B, Xie J (2004) Increased dopamine release in vivo by estradiol benzoate from the central amygdaloid nucleus of Parkinson\u2019s disease model rats. J Neurochem 90(3):654\u2013658","journal-title":"J Neurochem"},{"issue":"2","key":"1969_CR65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neures.2007.10.005","volume":"60","author":"L-X Liu","year":"2008","unstructured":"Liu L-X, Chen W-F, Xie J-X, Wong M-S (2008) Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson\u2019s disease. Neurosci Res 60(2):156\u2013161","journal-title":"Neurosci Res"},{"issue":"7","key":"1969_CR66","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.25771","volume":"29","author":"R Liu","year":"2014","unstructured":"Liu R, Baird D, Park Y, Freedman ND, Huang X, Hollenbeck A, Chen H (2014) Female reproductive factors, menopausal hormone use, and Parkinson\u2019s disease. Mov Disord 29(7):889\u2013896","journal-title":"Mov Disord"},{"issue":"1","key":"1969_CR67","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s40168-022-01356-2","volume":"10","author":"Y Ma","year":"2022","unstructured":"Ma Y, Liu T, Li X, Kong A, Xiao R, Xie R, Fan X (2022) Estrogen receptor \u03b2 deficiency impairs gut microbiota: a possible mechanism of IBD-induced anxiety-like behavior. Microbiome 10(1):160. https:\/\/doi.org\/10.1186\/s40168-022-01356-2","journal-title":"Microbiome"},{"issue":"9","key":"1969_CR68","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1021\/cn400132u","volume":"4","author":"K McFarland","year":"2013","unstructured":"McFarland K, Price DL, Davis CN, Ma JN, Bonhaus DW, Burstein ES, Olsson R (2013) AC-186, a selective nonsteroidal estrogen receptor \u03b2 agonist, shows gender specific neuroprotection in a Parkinson\u2019s disease rat model. ACS Chem Neurosci 4(9):1249\u20131255. https:\/\/doi.org\/10.1021\/cn400132u","journal-title":"ACS Chem Neurosci"},{"key":"1969_CR69","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbi.2017.04.016","volume":"64","author":"J Mendes-Oliveira","year":"2017","unstructured":"Mendes-Oliveira J, Campos FL, Videira RA, Baltazar G (2017) GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment. Brain Behav Immun 64:296\u2013307","journal-title":"Brain Behav Immun"},{"key":"1969_CR70","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2016.01.046","volume":"616","author":"S Mitra","year":"2016","unstructured":"Mitra S, Ghosh N, Sinha P, Chakrabarti N, Bhattacharyya A (2016) Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Neurosci Lett 616:86\u201392. https:\/\/doi.org\/10.1016\/j.neulet.2016.01.046","journal-title":"Neurosci Lett"},{"issue":"2","key":"1969_CR71","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/10717544.2013.838713","volume":"21","author":"D Mittal","year":"2014","unstructured":"Mittal D, Ali A, Md S, Baboota S, Sahni JK, Ali J (2014) Insights into direct nose to brain delivery: current status and future perspective. Drug Delivery 21(2):75\u201386","journal-title":"Drug Delivery"},{"issue":"5","key":"1969_CR72","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.29369","volume":"38","author":"L Mu\u00f1oz-Delgado","year":"2023","unstructured":"Mu\u00f1oz-Delgado L, Labrador\u2010Espinosa M\u00c1, Mac\u00edas\u2010Garc\u00eda D, Jes\u00fas S, Zamora B, Fern\u00e1ndez\u2010Rodr\u00edguez B, Silva\u2010Rodr\u00edguez P, J (2023) Peripheral inflammation is associated with dopaminergic degeneration in Parkinson\u2019s disease. Mov Disord 38(5):755\u2013763","journal-title":"Mov Disord"},{"issue":"9","key":"1969_CR74","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.bbadis.2014.04.008","volume":"1842","author":"K Nakaso","year":"2014","unstructured":"Nakaso K, Tajima N, Horikoshi Y, Nakasone M, Hanaki T, Kamizaki K, Matsura T (2014) The estrogen receptor \u03b2-PI3K\/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson\u2019s disease model. Biochim Biophys Acta 1842(9):1303\u20131312. https:\/\/doi.org\/10.1016\/j.bbadis.2014.04.008","journal-title":"Biochim Biophys Acta"},{"key":"1969_CR73","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neulet.2015.10.062","volume":"610","author":"K Nakaso","year":"2016","unstructured":"Nakaso K, Horikoshi Y, Takahashi T, Hanaki T, Nakasone M, Kitagawa Y, Matsura T (2016) Estrogen receptor-mediated effect of \u03b4-tocotrienol prevents neurotoxicity and motor deficit in the MPTP mouse model of Parkinson\u2019s disease. Neurosci Lett 610:117\u2013122. https:\/\/doi.org\/10.1016\/j.neulet.2015.10.062","journal-title":"Neurosci Lett"},{"issue":"7","key":"1969_CR75","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/cb1000636","volume":"5","author":"TK Nayak","year":"2010","unstructured":"Nayak TK, Dennis MK, Ramesh C, Burai R, Atcher RW, Sklar LA, Prossnitz ER (2010) Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents. ACS Chem Biol 5(7):681\u2013690","journal-title":"ACS Chem Biol"},{"issue":"10","key":"1969_CR76","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nrd3551","volume":"10","author":"S Nilsson","year":"2011","unstructured":"Nilsson S, Koehler KF, Gustafsson J-\u00c5 (2011) Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discovery 10(10):778\u2013792","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"1969_CR77","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G (2020) BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci 21(3):1170","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1969_CR78","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2(1):3\u201314","journal-title":"NeuroRx"},{"issue":"4","key":"1969_CR79","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/nu15040954","volume":"15","author":"S Park","year":"2023","unstructured":"Park S, Sim K-S, Heo W, Kim J-H (2023) Protective effects of coumestrol on metabolic dysfunction and its estrogen receptor-mediated action in ovariectomized mice. Nutrients 15(4):954","journal-title":"Nutrients"},{"issue":"7","key":"1969_CR80","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1002\/ptr.7861","volume":"37","author":"S Patra","year":"2023","unstructured":"Patra S, Gorai S, Pal S, Ghosh K, Pradhan S, Chakrabarti S (2023) A review on phytoestrogens: Current status and future direction. Phytother Res 37(7):3097\u20133120","journal-title":"Phytother Res"},{"key":"1969_CR81","first-page":"1","volume-title":"Therapeutic effect of formononetin in 6-OHDA induced Parkinson disease in rats","author":"TD Pingale","year":"2025","unstructured":"Pingale TD, Gupta GL (2025) Therapeutic effect of formononetin in 6-OHDA induced Parkinson disease in rats. Inflammopharmacology, pp 1\u201311"},{"key":"1969_CR83","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2016.08.004","volume":"48","author":"A-A Poirier","year":"2016","unstructured":"Poirier A-A, C\u00f4t\u00e9 M, Bourque M, Morissette M, Di Paolo T, Soulet D (2016) Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson\u2019s disease. Neurobiol Aging 48:61\u201371","journal-title":"Neurobiol Aging"},{"key":"1969_CR82","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainresbull.2022.06.019","volume":"187","author":"A-A Poirier","year":"2022","unstructured":"Poirier A-A, C\u00f4t\u00e9 M, Bourque M, Jarras H, Lamontagne-Proulx J, Morissette M, Soulet D (2022) Differential contribution of estrogen receptors to the intestinal therapeutic effects of 17\u03b2-estradiol in a murine model of Parkinson\u2019s disease. Brain Res Bull 187:85\u201397","journal-title":"Brain Res Bull"},{"key":"1969_CR84","doi-asserted-by":"publisher","first-page":"1310432","DOI":"10.3389\/fendo.2023.1310432","volume":"14","author":"K Prokai-Tatrai","year":"2024","unstructured":"Prokai-Tatrai K, Prokai L (2024) The impact of 17\u03b2-estradiol on the estrogen-deficient female brain: from mechanisms to therapy with hot flushes as target symptoms. Front Endocrinol 14:1310432","journal-title":"Front Endocrinol"},{"key":"1969_CR85","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/B978-0-443-23763-8.00060-9","volume-title":"Neuroprotection by estrogens. Natural Molecules in Neuroprotection and Neurotoxicity","author":"K Prokai-Tatrai","year":"2024","unstructured":"Prokai-Tatrai K, Zaman K, Prokai L (2024) Neuroprotection by estrogens. Natural Molecules in Neuroprotection and Neurotoxicity. Elsevier, pp 549\u2013570"},{"issue":"12","key":"1969_CR86","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nrendo.2011.122","volume":"7","author":"ER Prossnitz","year":"2011","unstructured":"Prossnitz ER, Barton M (2011) The G-protein-coupled estrogen receptor GPER in health and disease. Nat Reviews Endocrinol 7(12):715\u2013726","journal-title":"Nat Reviews Endocrinol"},{"issue":"7","key":"1969_CR87","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41574-023-00822-7","volume":"19","author":"ER Prossnitz","year":"2023","unstructured":"Prossnitz ER, Barton M (2023) The G protein-coupled oestrogen receptor GPER in health and disease: an update. Nat Reviews Endocrinol 19(7):407\u2013424","journal-title":"Nat Reviews Endocrinol"},{"issue":"1","key":"1969_CR88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/jnr.10833","volume":"75","author":"A Quesada","year":"2004","unstructured":"Quesada A, Micevych PE (2004) Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6\u2010hydroxdopamine lesions. J Neurosci Res 75(1):107\u2013116","journal-title":"J Neurosci Res"},{"issue":"3","key":"1969_CR89","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1021\/jm9011802","volume":"53","author":"C Ramesh","year":"2010","unstructured":"Ramesh C, Nayak TK, Burai R, Dennis MK, Hathaway HJ, Sklar LA, Arterburn JB (2010) Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30. J Med Chem 53(3):1004\u20131014","journal-title":"J Med Chem"},{"issue":"5715","key":"1969_CR90","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1126\/science.1106943","volume":"307","author":"CM Revankar","year":"2005","unstructured":"Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307(5715):1625\u20131630","journal-title":"Science"},{"issue":"5","key":"1969_CR91","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","volume":"130","author":"P Riederer","year":"2023","unstructured":"Riederer P, Nagatsu T, Youdim MB, Wulf M, Dijkstra JM, Sian-Huelsmann J (2023) Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson\u2019s disease. J Neural Transm 130(5):627\u2013646","journal-title":"J Neural Transm"},{"key":"1969_CR92","doi-asserted-by":"crossref","unstructured":"Rymbai E, Sugumar D, Chakkittukandiyil A, Kothandan R, Selvaraj D (2024) Molecular insights into the potential effects of selective estrogen receptor \u03b2 agonists in Alzheimer\u2019s and Parkinson\u2019s diseases. Cell Biochem Funct, 42(3), e4014","DOI":"10.1002\/cbf.4014"},{"issue":"8","key":"1969_CR93","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1002\/jcp.26412","volume":"233","author":"RM Salama","year":"2018","unstructured":"Salama RM, Tadros MG, Schaalan MF, Bahaa N, Abdel-Tawab AM, Khalifa AE (2018) Potential neuroprotective effect of androst-5-ene-3\u03b2, 17\u03b2-diol (ADIOL) on the striatum, and substantia nigra in Parkinson\u2019s disease rat model. J Cell Physiol 233(8):5981\u20136000. https:\/\/doi.org\/10.1002\/jcp.26412","journal-title":"J Cell Physiol"},{"issue":"2","key":"1969_CR94","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.neulet.2011.11.032","volume":"506","author":"M San Luciano","year":"2012","unstructured":"San Luciano M, Ozelius L, Lipton RB, Raymond D, Bressman SB, Saunders-Pullman R (2012) Gender differences in the IL6 -174G\u2009>\u2009C and ESR2 1730G\u2009>\u2009A polymorphisms and the risk of Parkinson\u2019s disease. Neurosci Lett 506(2):312\u2013316. https:\/\/doi.org\/10.1016\/j.neulet.2011.11.032","journal-title":"Neurosci Lett"},{"issue":"6","key":"1969_CR95","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.pharep.2017.06.008","volume":"69","author":"D Shen","year":"2017","unstructured":"Shen D, Tian X, Zhang B, Song R (2017) Mechanistic evaluation of neuroprotective effect of estradiol on rotenone and 6-OHDA induced Parkinson\u2019s disease. Pharmacol Rep 69(6):1178\u20131185","journal-title":"Pharmacol Rep"},{"issue":"2","key":"1969_CR96","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.expneurol.2004.08.009","volume":"190","author":"PJ Shughrue","year":"2004","unstructured":"Shughrue PJ (2004) Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ER\u03b1 and ER\u03b2). Exp Neurol 190(2):468\u2013477","journal-title":"Exp Neurol"},{"issue":"5","key":"1969_CR97","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/19390211.2018.1472706","volume":"16","author":"YH Siddique","year":"2019","unstructured":"Siddique YH, Naz F, Jyoti S, Ali F, Rahul (2019) Effect of genistein on the transgenic drosophila model of Parkinson\u2019s disease. J Diet supplements 16(5):550\u2013563","journal-title":"J Diet supplements"},{"issue":"1","key":"1969_CR98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0006-291X(69)90540-3","volume":"34","author":"MS Soloff","year":"1969","unstructured":"Soloff MS, Szego CM (1969) Purification of estradiol receptor from rat uterus and blockade of its estrogen-binding function by specific antibody. Biochem Biophys Res Commun 34(1):141\u2013147","journal-title":"Biochem Biophys Res Commun"},{"key":"1969_CR99","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fnins.2020.00157","volume":"14","author":"Y-j Song","year":"2020","unstructured":"Song Y-j, Li S-r, Li X-w, Chen X, Wei Z-x, Liu Q-s, Cheng Y (2020) The effect of estrogen replacement therapy on Alzheimer\u2019s disease and Parkinson\u2019s disease in postmenopausal women: a meta-analysis. Front NeuroSci 14:157","journal-title":"Front NeuroSci"},{"issue":"5","key":"1969_CR101","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s10787-024-01510-2","volume":"32","author":"D Soni","year":"2024","unstructured":"Soni D, Upadhayay S, Dhureja M, Arthur R, Kumar P (2024) Crosstalk between gut\u2013brain axis: unveiling the mysteries of gut ROS in progression of Parkinson\u2019s disease. Inflammopharmacology 32(5):2921\u20132941","journal-title":"Inflammopharmacology"},{"key":"1969_CR100","doi-asserted-by":"publisher","first-page":"177523","DOI":"10.1016\/j.ejphar.2025.177523","volume":"998","author":"D Soni","year":"2025","unstructured":"Soni D, Garg Y, Upadhayay S, Bhatia A, Basir B, Singh SK, Kumar P (2025) Auranofin-loaded chitosan-lipid hybrid nanoparticle protects against rotenone model of Parkinson\u2019s disease via modulation of GSK-3\u03b2\/Nrf2\/HO-1 signaling. Eur J Pharmacol 998:177523","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1969_CR102","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/ijms24010507","volume":"24","author":"E Szczurowska","year":"2022","unstructured":"Szczurowska E, Sz\u00e1nti-Pint\u00e9r E, Chetverikov N, Rand\u00e1kov\u00e1 A, Kudov\u00e1 E, Jakub\u00edk J (2022) Modulation of muscarinic signalling in the central nervous system by steroid hormones and neurosteroids. Int J Mol Sci 24(1):507","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1969_CR103","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1073\/pnas.52.4.1059","volume":"52","author":"G Talwar","year":"1964","unstructured":"Talwar G, Segal SJ, Evans A, Davidson O (1964) The binding of estradiol in the uterus: a mechanism for derepression of RNA synthesis. Proc Natl Acad Sci 52(4):1059\u20131066","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1969_CR104","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1677\/jme.0.0240145","volume":"24","author":"A Taylor","year":"2000","unstructured":"Taylor A, Al-Azzawi F (2000) Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 24(1):145","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"1969_CR105","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11481-020-09972-1","volume":"16","author":"N Thadathil","year":"2021","unstructured":"Thadathil N, Xiao J, Hori R, Alway SE, Khan MM (2021) Brain selective estrogen treatment protects dopaminergic neurons and preserves behavioral function in MPTP-induced mouse model of Parkinson\u2019s disease. J Neuroimmune Pharmacol 16(3):667\u2013678","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"1969_CR106","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1210\/en.2004-1064","volume":"146","author":"P Thomas","year":"2005","unstructured":"Thomas P, Pang Y, Filardo EJ, Dong J (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146(2):624\u2013632","journal-title":"Endocrinology"},{"key":"1969_CR107","doi-asserted-by":"publisher","first-page":"971007","DOI":"10.3389\/fnagi.2022.971007","volume":"14","author":"SR Unda","year":"2022","unstructured":"Unda SR, Marciano S, Milner TA, Marongiu R (2022) State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson\u2019s disease: What meta-analysis studies cannot tell us. Front Aging Neurosci 14:971007","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"1969_CR108","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s10571-022-01301-9","volume":"43","author":"S Upadhayay","year":"2023","unstructured":"Upadhayay S, Gupta R, Singh S, Mundkar M, Singh G, Kumar P (2023) Involvement of the G-Protein-Coupled Estrogen Receptor-1 (GPER) Signaling Pathway in Neurodegenerative Disorders: A Review. Cell Mol Neurobiol 43(5):1833\u20131847. https:\/\/doi.org\/10.1007\/s10571-022-01301-9","journal-title":"Cell Mol Neurobiol"},{"issue":"8","key":"1969_CR109","doi-asserted-by":"publisher","first-page":"e70413","DOI":"10.1002\/jbt.70413","volume":"39","author":"S Upadhayay","year":"2025","unstructured":"Upadhayay S, Soni D, Kumar P (2025a) Raloxifene and Fulvestrant Exert Antioxidant, Anti-Inflammatory, and Antiapoptotic Action Against Haloperidol\u2010Induced Tardive Dyskinesia in Rats via Activation of the GPER1\/PI3k\/Akt\/Nrf2\/HO\u20101 Signaling Pathways. J Biochem Mol Toxicol 39(8):e70413","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"1969_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-025-04369-z","volume":"50","author":"S Upadhayay","year":"2025","unstructured":"Upadhayay S, Uttam V, Kumar P (2025b) G-Protein-Coupled Estrogen Receptor 1 (GPER1) Activation Mitigates Haloperidol-Induced Neurotoxicity in SHSY-5Y Cells and Improves Motor Functions in Adult Zebrafish. Neurochem Res 50(2):1\u201318","journal-title":"Neurochem Res"},{"issue":"20","key":"1969_CR111","doi-asserted-by":"publisher","first-page":"7586","DOI":"10.3390\/ijms21207586","volume":"21","author":"L Veenman","year":"2020","unstructured":"Veenman L (2020) Raloxifene as treatment for various types of brain injuries and neurodegenerative diseases: a good start. Int J Mol Sci 21(20):7586","journal-title":"Int J Mol Sci"},{"key":"1969_CR112","doi-asserted-by":"publisher","first-page":"1644615","DOI":"10.3389\/fnbeh.2025.1644615","volume":"19","author":"NL Walton","year":"2025","unstructured":"Walton NL, Maguire JL (2025) Neurosteroids: a lifelong impact on brain health. Front Behav Neurosci 19:1644615","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"1969_CR114","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12640-016-9648-y","volume":"30","author":"J Wang","year":"2016","unstructured":"Wang J, Wu W-Y, Huang H, Li W-Z, Chen H-Q, Yin Y-Y (2016) Biochanin A protects against lipopolysaccharide-induced damage of dopaminergic neurons both in vivo and in vitro via inhibition of microglial activation. Neurotox Res 30(3):486\u2013498","journal-title":"Neurotox Res"},{"issue":"4","key":"1969_CR116","doi-asserted-by":"publisher","first-page":"E734","DOI":"10.1152\/ajpendo.00071.2020","volume":"319","author":"X-W Wang","year":"2020","unstructured":"Wang X-W, Yuan L-J, Yang Y, Zhang M, Chen W-F (2020) IGF-1 inhibits MPTP\/MPP+-induced autophagy on dopaminergic neurons through the IGF-1R\/PI3K-Akt-mTOR pathway and GPER. Am J Physiology-Endocrinology Metabolism 319(4):E734\u2013E743","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"8","key":"1969_CR115","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1007\/s12035-022-02894-4","volume":"59","author":"S Wang","year":"2022","unstructured":"Wang S, Zhang Z, Wang J, Ma L, Zhao J, Wang J, Guo H (2022) Neuronal GPER participates in genistein-mediated neuroprotection in ischemic stroke by inhibiting NLRP3 inflammasome activation in ovariectomized female mice. Mol Neurobiol 59(8):5024\u20135040","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1969_CR113","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41420-024-02273-z","volume":"10","author":"G Wang","year":"2024","unstructured":"Wang G, Zhuang W, Zhou Y, Wang X, Li Z, Liu C, Lv E (2024) 17\u03b2-estradiol alleviated ferroptotic neuroinflammation by suppressing ATF4 in mouse model of Parkinson\u2019s disease. Cell Death Discovery 10(1):507","journal-title":"Cell Death Discovery"},{"issue":"8","key":"1969_CR117","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.psyneuen.2003.08.010","volume":"29","author":"L Westberg","year":"2004","unstructured":"Westberg L, H\u00e5kansson A, Melke J, Shahabi HN, Nilsson S, Buervenich S, Nissbrandt H (2004) Association between the estrogen receptor beta gene and age of onset of Parkinson\u2019s disease. Psychoneuroendocrinology 29(8):993\u2013998. https:\/\/doi.org\/10.1016\/j.psyneuen.2003.08.010","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"1969_CR118","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.4103\/1673-5374.235250","volume":"13","author":"H-C Wu","year":"2018","unstructured":"Wu H-C, Hu Q-L, Zhang S-J, Wang Y-M, Jin Z-K, Lv L-F, Cheng O-M (2018) Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant \u03b1-synuclein. Neural regeneration Res 13(8):1375\u20131383","journal-title":"Neural regeneration Res"},{"key":"1969_CR119","doi-asserted-by":"crossref","unstructured":"Wu Q, Wang M, Chen W, Wang K, Wang Y (2022) Daidzein exerts neuroprotective activity against MPTP-induced Parkinson\u2019s disease in experimental mice and lipopolysaccharide\u2010induced BV2 microglial cells. J Biochem Mol Toxicol, 36(2), e22949","DOI":"10.1002\/jbt.22949"},{"key":"1969_CR120","doi-asserted-by":"publisher","first-page":"114104","DOI":"10.1016\/j.intimp.2025.114104","volume":"148","author":"Y Xie","year":"2025","unstructured":"Xie Y, Chen J, Xu S, Cheng O (2025) Estrogen deficiency promotes neurodegeneration in female hemi-parkinsonian mice: The role of regulatory T cells. Int Immunopharmacol 148:114104","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1969_CR121","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biology12010099","volume":"12","author":"J Xu","year":"2023","unstructured":"Xu J, Bai J, Gao F, Xu C, Huang Y, Li D, Wang R (2023) Anti-inflammatory actions of G-protein-coupled estrogen receptor 1 (GPER) and brain-derived estrogen following cerebral ischemia in ovariectomized rats. Biology 12(1):99","journal-title":"Biology"},{"issue":"9","key":"1969_CR122","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3390\/biomedicines13092283","volume":"13","author":"S Yeo","year":"2025","unstructured":"Yeo S (2025) Recent Advances in Parkinson\u2019s Disease Research: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 13(9):2283","journal-title":"Biomedicines"},{"key":"1969_CR123","doi-asserted-by":"publisher","first-page":"111053","DOI":"10.1016\/j.mce.2020.111053","volume":"519","author":"L-J Yuan","year":"2021","unstructured":"Yuan L-J, Zhang M, Chen S, Chen W-F (2021) Anti-inflammatory effect of IGF-1 is mediated by IGF-1R cross talk with GPER in MPTP\/MPP+-induced astrocyte activation. Mol Cell Endocrinol 519:111053","journal-title":"Mol Cell Endocrinol"},{"key":"1969_CR125","doi-asserted-by":"publisher","first-page":"113955","DOI":"10.1016\/j.biopha.2022.113955","volume":"156","author":"M Zhang","year":"2022","unstructured":"Zhang M, Hu Z-F, Dong X-L, Chen W-F (2022) Epimedin B exerts neuroprotective effect against MPTP-induced mouse model of Parkinson\u2019s disease: GPER as a potential target. Biomed Pharmacother 156:113955","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1969_CR126","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12974-024-03152-1","volume":"21","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tan X, Tang C (2024) Estrogen-immuno-neuromodulation disorders in menopausal depression. J Neuroinflamm 21(1):159","journal-title":"J Neuroinflamm"},{"key":"1969_CR124","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04707-6","author":"D Zhang","year":"2025","unstructured":"Zhang D, Xu C, Tang B, Dai Y, Guo S, Fu Z, Zhao X (2025) Tenuigenin targets Trim31 and NF-\u03baB pathway to protect dopaminergic neurons in Parkinson\u2019s disease mice. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04707-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1969_CR127","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jare.2024.06.004","volume":"71","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Guo Y, Guo P, Zhang J, He Y, Xia Y, Dai Y (2025) Estrogen receptor \u03b2 activation alleviates inflammatory bowel disease by suppressing NLRP3-dependent IL-1\u03b2 production in macrophages via downregulation of intracellular calcium level. J Adv Res 71:571\u2013584","journal-title":"J Adv Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01969-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01969-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01969-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:03:04Z","timestamp":1788152584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01969-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1969"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01969-8","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"198"}}